Celgene (CELG), Acceleron (XLRN) Present Encouraging Sotatercept Phase 2 Data in Myelofibrosis
Tweet Send to a Friend
Acceleron Pharma Inc. (Nasdaq: XLRN) and Celgene Corporation (Nasdaq: CELG), announced preliminary results from an ongoing investigator initiated Phase 2 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE